Chauhan Sukhjinder, Valenta Jordan, Dhillon Gundip S, Phan Preston, Huh Yongwoon, Manov Andre E, Wierman Ann
Internal Medicine, MountainView Hospital, Las Vegas, USA.
Medicine, Touro University Nevada, Henderson, USA.
Cureus. 2023 Jul 26;15(7):e42516. doi: 10.7759/cureus.42516. eCollection 2023 Jul.
This report describes the case of a 73-year-old female patient who presented with abdominal symptoms. A colonoscopy identified a cecal mass confirmed as mantle cell lymphoma (MCL). Imaging showed extensive lymph node involvement. The patient received rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone (R-CHOP) chemotherapy, resulting in tumor reduction and adenopathy resolution. Despite a typically unfavorable prognosis associated with a high Ki-67 index, the patient responded well to chemotherapy and achieved a favorable outcome. This case highlights the importance of early detection, appropriate treatment which in our case was R-CHOP, and personalized management approaches in addressing MCL.
本报告描述了一名73岁出现腹部症状的女性患者的病例。结肠镜检查发现盲肠肿块,确诊为套细胞淋巴瘤(MCL)。影像学检查显示有广泛的淋巴结受累。患者接受了利妥昔单抗、环磷酰胺、羟基柔红霉素、长春新碱和泼尼松(R-CHOP)化疗,肿瘤缩小且淋巴结病消退。尽管通常与高Ki-67指数相关的预后不佳,但该患者对化疗反应良好并取得了良好的结果。该病例突出了早期检测、在我们的病例中为R-CHOP的适当治疗以及个性化管理方法在应对MCL方面的重要性。